High remission rates and visual network normalization in severely traumatized children following medication-free, intensive inpatient psychotherapy

1. Abstract Children exposed to severe childhood maltreatment often develop complex mental health disorders where standard treatments show limited efficacy. Current residential approaches combine psychopharmacological with behavioural interventions, yet the feasibility and clinical-neurobiological outcomes of intensive, medication-free psychotherapy have not been investigated in this population. Our prospective study followed severely traumatized children (aged 6-13 years) with documented histories of changes and failures in placement.They completed an intensive 6-8 months inpatient treatment program (5 individual psychotherapy and 3 group therapy sessions per week with high caregiver-patient ratio) grounded in a novel, multimodal, attachment-based therapeutic framework. Medication was discontinued prior to treatment. The intervention group was compared to healthy controls and waitlist controls receiving treatment as usual. Participants in the intervention group achieved high remission rates for dysregulated behaviour (Child Behaviour Checklist (CBCL) >60% post treatment, 50% on follow-up) and trauma-related symptoms (Parent Report of Post-traumatic Stress Symptoms (PROPS) >65% post treatment, >60% on follow-up). Within-group effect sizes for Total Problems Score, Externalising behaviour (both CBCL), Hyperactivity (Strengths and Difficulties Questionnaire) and trauma symptoms (PROPS) each exceeded Cohen’s d = 1.0 and were maintained at 6-month follow-up. Resting-state fMRI identified significant functional reorganization in visual processing networks. Atypical correlation patterns between visual network activity and symptom severity resolved following treatment, yielding patterns comparable to those of healthy controls. These pilot findings provide initial evidence of the feasibility and effectiveness of intensive, medication-free, attachment-based inpatient treatment to promote clinical remission and neurobiological normalization in severely traumatized children.